These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10349062)

  • 1. Raloxifene: designer estrogen for preventing postmenopausal osteoporosis.
    Park L; Evans MF
    Can Fam Physician; 1999 May; 45():1191-3. PubMed ID: 10349062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current trends in prevention and therapy of postmenopausal osteoporosis].
    Rossi G
    Recenti Prog Med; 1998 Jun; 89(6):288. PubMed ID: 9658894
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):29-30. PubMed ID: 9529516
    [No Abstract]   [Full Text] [Related]  

  • 5. Raloxifene: a selective estrogen receptor modulator.
    Scott JA; Da Camara CC; Early JE
    Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raloxifene].
    Hofbauer LC; Heufelder AE
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):19-20. PubMed ID: 9951454
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen for prevention of breast cancer.
    Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486
    [No Abstract]   [Full Text] [Related]  

  • 8. Raloxifene: a new class of anti-estrogens for the prevention of osteoporosis.
    Kupecz D
    Nurse Pract; 1998 Sep; 23(9):91-3. PubMed ID: 9778672
    [No Abstract]   [Full Text] [Related]  

  • 9. A new alternative to estrogen: raloxifene.
    Runowicz C
    Health News; 1998 Jun; 4(8):4. PubMed ID: 9644506
    [No Abstract]   [Full Text] [Related]  

  • 10. From blunderbuss to magic bullet?
    Alderman C
    Nurs Stand; 1998 Jan 21-27; 12(18):18. PubMed ID: 9485842
    [No Abstract]   [Full Text] [Related]  

  • 11. [Raloxifene hydrochloride].
    Itabashi A
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():528-35. PubMed ID: 15035185
    [No Abstract]   [Full Text] [Related]  

  • 12. Designer estrogens: breast cancer benefit, remaining questions.
    Health News; 1999 Jul; 5(9):6. PubMed ID: 10480007
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical efficacy of SERMs.
    Dere WH
    Aging (Milano); 1998 Apr; 10(2):160-1. PubMed ID: 9666217
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
    Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
    Schaefers M; Muysers C; Alexandersen P; Christiansen C
    Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of raloxifene in postmenopausal women.
    Friedman MN
    N Engl J Med; 1998 Apr; 338(18):1313; author reply 1313-4. PubMed ID: 9565493
    [No Abstract]   [Full Text] [Related]  

  • 19. New drug approved to help prevent osteoporosis.
    Mayo Clin Health Lett; 1998 Mar; 16(3):3. PubMed ID: 9516369
    [No Abstract]   [Full Text] [Related]  

  • 20. Using SERMS for treating postmenopausal symptoms.
    Brockie J
    Community Nurse; 1999 Jan; 4(12):30-1. PubMed ID: 10326399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.